Study Finds Guideline-Concordant Cervical Cancer Screening Dropped From 2005 to 2019 Among Women in the United States
Rates of cervical cancer screening have dropped recently in the United States, with screening rates lowest among Asian and Hispanic women, as well as women who live in rural areas, are uninsured, or are sexual minorities, according to findings published by Ryan Suk, PhD, and colleagues in JAMA Network Open.
The nationally representative, cross-sectional study of 20,557 women revealed a major uptick in the proportion in women without an up-to-date cervical cancer screening among all sociodemographic groups—from 14.4% in 2005 to 23.0% in 2019. The study pulled data from the National Health Information Survey (NHIS) from the Centers for Disease Control and Prevention. Major disparities were found across different sociodemographic groups. Still, the most commonly reported reason for not receiving a timely screening across all groups was lack of knowledge, ranging from 47.2% of women identifying as LGBQ+ (defined as lesbian, gay, bisexual, other, or unsure) to 64.4% of women with Hispanic ethnicity.
Ryan Suk, PhD
“What this means is that more campaigns about cervical cancer screenings are needed,” said Dr. Suk, Assistant Professor of Management, Policy, and Community Health at UTHealth School of Public Health. “There would need to be targeted, culturally adapted campaigns for each of these sociodemographic groups.”
Additional Findings
Significantly higher rates of overdue screening were found among women of Asian descent compared with those of non-Hispanic White race and ethnicity (31.4% vs 20.1%). There were also higher rates of overdue screening among women living in rural vs urban areas (26.2% vs 22.6%), those without insurance vs those with private insurance (41.7% vs 18.1%), and women who identified as LGBQ+ vs heterosexual (32.0% vs 22.2%). Transgender individuals could not be identified because the NHIS data does not have information on transgender people and only includes a binary sex variable of male and female.
Other key findings include:
- Both Asian and Hispanic women were more likely to have a screening that was not up to date compared with non-Hispanic White women, but the reasons varied across race and ethnicity. Although both Asian and Hispanic women reported lack of knowledge as a barrier, Asian women were more likely to report lack of recommendation from a health-care professional and perception of no problems as barriers, whereas Hispanic women were twice as likely as Asian women to report lack of access as a barrier.
- There were also disparities in screening rates across age groups. In 2019, women aged 21 to 29 years had a significantly higher rate of overdue screening (29.1%) vs women aged 30 to 65 (21.1%). Previous receipt of a human papillomavirus (HPV) vaccine, which has been recommended to women up to age 26 since 2007, was not a primary reason for not having an up-to-date screening across either age group. However, among women in the older age group, those responding that they did not receive screening because they did not have a recommendation from their health-care practitioners doubled in 2019, from 5.5% to 12.0%.
- The proportion of women reporting lack of access as their primary barrier to receiving a timely screening decreased significantly from 2005 to 2019 across all age groups, possibly representing benefits from Medicaid expansion and the Affordable Care Act’s emphasis on access to the U.S. Preventive Services Task Force–recommended preventive cares.
Dr. Suk said that these findings underscore the importance of recommendations from health-care professionals in promoting cervical cancer screenings, which may play an even larger role as access to care continues to improve.
“Timely cervical cancer screening is a crucial prevention measure of cervical cancer, especially for those who could not benefit from the introduction of HPV vaccine,” she said. “Most cervical cancer cases are preventable, and we need to spend more efforts on improving overall timely screening rate, but also on reducing disparities across diverse populations. This study emphasizes and reminds us that we need a more inclusive and sustainable approach in the implementation of this evidence-based screening strategy.”
Disclosure: For full disclosures of the study authors, visit jamanetwork.com.
The content in this post has not been reviewed by the American Society of Clinical Oncology, Inc. (ASCO®) and does not necessarily reflect the ideas and opinions of ASCO®.